Buscador de noticias

E.g., 09/02/2026
E.g., 09/02/2026
Foto
Research
5 Feb 2026

prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction.

Equipo del CNIC
Research
2 Feb 2026

A team from the CNIC and Hospital Clínico Universitario de Valladolid has developed a minimally invasive, catheter-based procedure to treat defective mechanical aortic valves

Dra. Ellie Tzima
From left to right: Miguel Sánchez Álvarez, Miguel Ángel del Pozo, David Sancho, Ignacio Heras Murillo, Gillian Dunphy, Aitor Jarit Cabanillas, Elena Moya Ruiz, Irene Adán Barrientos
Research
28 Jan 2026

study published in Immunity reveals that type I interferons (IFN‑I) help resolve inflammation by inducing changes in macrophage mitochondria

Jorge Alegre and Travis Hinson
Equipo de investigadores del CNIC liderados por la Dr. Mª Ángeles Moro. De izquierda a derecha, primera fila: Ignacio Lizasoain, Gaohong Di, Maria Angeles Moro, Alicia García-Culebras, Maria Isabel Cuartero, Francisco J. de Castro-Millan, Abndrea Rubio-Ponce, Carlos Parra-Pérez, Christina Reyburn-Valés, Carlona Peña-Martinez, Marta Marty. Segunda fila: Francisco Cantero-Molina, Eneko Merino-Casamayor, Virginia García-Sánchez, Laiura Martínez-. Cortés, Hana Matuskova, Emily McMahon
Research
20 Jan 2026

The study, published in Circulation Research, reveals that neutrophils—key immune cells—change their behavior in line with circadian rhythms, affecting cerebral perfusion and collateral circulation

Dr. Borja Ibáñez
Research
14 Jan 2026

A CNIC research team has identified for the first time the biological mechanism underlying this susceptibility: high blood pressure creates a hidden metabolic vulnerability in the heart that becomes destabilized when anthracyclines are administered.

Héctor Bueno JACARDI
About the CNIC
15 Dec 2025

A new policy paper highlights key areas for advancing data-driven policymaking to curb the rising burden of non-communicable diseases (NCDs), setting the stage for a more effective and equitable healthcare in Europe 

Protection against blood vessel occlusion in animals with sickle cell anemia after treatment with circadian clock inhibitors. Vessel walls are shown as white lines, neutrophils in yellow, and red blood cells trapped by neutrophils in red.
Research
12 Dec 2025

A CNIC study reveals that neutrophils—a type of immune cell—are less aggressive at night, explaining why nighttime heart attacks are less severe than those occurring during the day